Tian Zhang, M.D.

  • Internal Medicine - Hematology/Oncology
  • Genitourinary Cancer
  • Kidney Cancer


Tian Zhang, M.D., M.H.S., is an Associate Professor in the Department of Internal Medicine at UT Southwestern Medical Center. She specializes in the diagnosis and treatment of genitourinary malignancies, including kidney, prostate, bladder, and testicular cancers.

Dr. Zhang earned her medical degree from the Harvard-MIT Health Sciences and Technology (HST) program at Harvard Medical School. She completed a residency in internal medicine at Duke University, where she also received advanced training through a hematology-oncology fellowship. In addition, she earned a Master of Health Sciences in the Clinical Research Training Program at Duke in 2019.

Certified by the American Board of Internal Medicine in medical oncology, she joined the UT Southwestern faculty in 2021.

Dr. Zhang is a clinical trialist and translational researcher focused on evaluating clinical development of novel therapeutics and evaluating biomarkers for genitourinary malignancies. She partners closely with a multidisciplinary team at UT Southwestern to provide data-driven clinical care for her patients.

She has gained an international reputation developing clinical trials in kidney, prostate, and bladder cancers. She serves as the study chair for PDIGREE, a phase III trial in metastatic renal cell carcinoma.

Dr. Zhang is a member of several professional organizations, including the American Society of Clinical Oncology (ASCO), the American Association for Cancer Research (AACR), and the European Society for Medical Oncology (ESMO).

She serves on numerous committees, including as Co-chair of the National Cancer Institute Genitourinary (GU) Steering Committee Renal Task Force and as Chair of the Chinese American Hematologist and Oncologist Network (CAHON) Academic Committee. She is a member of several ASCO clinical management guidelines committees as well as the Alliance for Clinical Trials in Oncology, GU Oncology, and Immuno-Oncology Committees.

She brings a track record of research and mentoring to UT Southwestern. She has received multiple peer-reviewed grants, a Resident Research Mentoring Award from Duke, and, notably, the 2021 Cancer Prevention & Research Institute of Texas (CPRIT) Scholar Rising Stars Award.

Education & Training
  • Other Post Graduate Training - Duke University School of Medicine (2013-2019)
  • Internship - Duke University (2009-2010)
  • Graduate School - Duke University Medical Center (2013-2019)
  • Fellowship - Duke University Medical Center (2012-2015), Hematology Oncology
  • Residency - Duke University Medical Center (2009-2012), Internal Medicine
  • Medical School - Harvard Medical School (2005-2009)
Professional Associations & Affiliations
  • American Society of Clinical Oncology
  • American Association for Cancer Research
  • European Society for Medical Oncology
  • Society for Immunotherapy of Cancer
  • Chinese American Hematologist and Oncologist Network
Honors & Awards
  • CPRIT Scholar Rising Stars Award 2021, Cancer Prevention & Research Institute of Texas (CPRIT)
  • Resident Research Mentoring Award 2020, Duke Department of Medicine
  • Women in Cancer Immunotherapy Network Leadership Institute 2019
  • Duke LEADER Program 2018
  • Conquer Cancer Foundation Merit Award 2015, ASCO
  • Methods in Clinical Cancer Research workshop 2014, AACR/ASCO
  • Conquer Cancer Foundation Merit Award 2013, ASCO
  • Molecular Biology in Clinical Oncology workshop 2013, AACR
  • Medicine House Staff Community Service Award 2012, Duke University
  • Phi Beta Kappa 2005, Columbia University
Books & Publications
  • Clinical investigation of novel and immune-based therapeutics
  • Evaluation of prognostic and predictive biomarkers in genitourinary malignancies
  • Translational evaluation of therapeutic targets in genitourinary malignancies

Clinical Focus

  • Genitourinary Cancer
  • Kidney Cancer
  • Prostate Cancer
  • Bladder Cancer
  • Testicular Cancer

See More